Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 21, 2023 Filed Apr 25, 2023 22:07 UTC |
Marsh Martha H.Director
|
Exercise / conversionCommon Stock | 1,458 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-025609 · doc4.xml · nonDerivative · entry 1 Marsh Martha H. · CIK 0001500281 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,498 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs"). Read SEC document |
| April 21, 2023 Filed Apr 25, 2023 22:06 UTC |
Jones Daphne EDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 1,458 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-025608 · doc4.xml · derivative · entry 2 Jones Daphne E · CIK 0001475924 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,458 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F3 · derivative.exercise_date: The RSUs identified in this row were granted on April 21, 2022 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2023, which will be held on May 17, 2023. Accordingly, the number of RSUs identified in this row vested on April 21, 2023. F4 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| April 21, 2023 Filed Apr 25, 2023 22:06 UTC |
Jones Daphne EDirector
|
Exercise / conversionCommon Stock | 1,458 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-025608 · doc4.xml · nonDerivative · entry 1 Jones Daphne E · CIK 0001475924 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,799 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs"). Read SEC document |
| April 21, 2023 Filed Apr 25, 2023 22:06 UTC |
HARRIS R JEFFREYDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 1,458 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-025607 · doc4.xml · derivative · entry 2 HARRIS R JEFFREY · CIK 0001183645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,458 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F3 · derivative.exercise_date: The RSUs identified in this row were granted on April 21, 2022 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2023, which will be held on May 17, 2023. Accordingly, the number of RSUs identified in this row vested on April 21, 2023. F4 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| April 21, 2023 Filed Apr 25, 2023 22:06 UTC |
HARRIS R JEFFREYDirector
|
Exercise / conversionCommon Stock | 1,458 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-025607 · doc4.xml · nonDerivative · entry 1 HARRIS R JEFFREY · CIK 0001183645 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,597 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs"). Read SEC document |
| April 21, 2023 Filed Apr 25, 2023 22:05 UTC |
FOLETTA MARK GDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 1,458 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-025606 · doc4.xml · derivative · entry 3 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,458 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock. F5 · derivative.exercise_date: The RSUs identified in this row were granted on April 21, 2022 and vest on the earlier of (i) the one year anniversary of the grant date, or (ii) the date of the Company's Annual Meeting of Shareholders in 2023, which will be held on May 17, 2023. Accordingly, the number of RSUs identified in this row vested on April 21, 2023. F6 · derivative.expiration_date: RSUs do not have an expiration date. Read SEC document |
| April 21, 2023 Filed Apr 25, 2023 22:05 UTC |
FOLETTA MARK GDirector
|
SaleCommon Stock | 1,458 | $88.78 | $129,441.24 |
DisclosureSEC source: 0001209191-23-025606 · doc4.xml · nonDerivative · entry 2 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,073 F2 · kind: The sale of 1,458 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported in this row represents a weighted average price of $88.78 per share. These shares were sold in multiple transactions at prices ranging from $88.43 to $89.08, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| April 21, 2023 Filed Apr 25, 2023 22:05 UTC |
FOLETTA MARK GDirector
|
Exercise / conversionCommon Stock | 1,458 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-025606 · doc4.xml · nonDerivative · entry 1 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,531 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: AMN Common Stock acquired on the vesting of Restricted Stock Units ("RSUs"). Read SEC document |
| April 11, 2023 Filed Apr 13, 2023 20:52 UTC |
FOLETTA MARK GDirector
|
SaleCommon Stock | 1,053 | $84.63 | $89,115.39 |
DisclosureSEC source: 0001209191-23-024223 · doc4.xml · nonDerivative · entry 2 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,073 F3 · kind: The sale of 1,053 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: The price reported in this row represents a weighted average price of $84.63 per share. These shares were sold in multiple transactions at prices ranging from $84.56 to $84.76, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| April 11, 2023 Filed Apr 13, 2023 20:52 UTC |
FOLETTA MARK GDirector
|
SaleCommon Stock | 4,989 | $84.29 | $420,522.81 |
DisclosureSEC source: 0001209191-23-024223 · doc4.xml · nonDerivative · entry 1 FOLETTA MARK G · CIK 0001236389 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,126 F1 · kind: The sale of 4,989 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported in this row represents a weighted average price of $84.29 per share. These shares were sold in multiple transactions at prices ranging from $83.535 to $84.535, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 09, 2023 Filed Mar 10, 2023 22:11 UTC |
Hagan Mark ChristopherChief Information and Digital
|
Tax withholdingCommon Stock | 1,291 | $88.47 | $114,214.77 |
DisclosureSEC source: 0001209191-23-017885 · doc4.xml · nonDerivative · entry 2 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,072 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
| March 09, 2023 Filed Mar 10, 2023 22:11 UTC |
Hagan Mark ChristopherChief Information and Digital
|
Exercise / conversionCommon Stock | 2,603 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-017885 · doc4.xml · nonDerivative · entry 1 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,363 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units (RSUs). Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 23:01 UTC |
Hagan Mark ChristopherChief Information and Digital
|
Tax withholdingCommon Stock | 2,953 | $97.49 | $287,887.97 |
DisclosureSEC source: 0001209191-23-010861 · doc4.xml · nonDerivative · entry 2 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,760 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 23:01 UTC |
Hagan Mark ChristopherChief Information and Digital
|
GrantCommon Stock | 6,031 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-010861 · doc4.xml · nonDerivative · entry 1 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,713 F1 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 6, 2020. The ultimate number of PRSUs that could have been earned and vested under this award depended on the Company achieving or exceeding, annual year-over-year performance targets based, on a consolidated basis, a certain specified adjusted earnings before interest, taxes, depreciation and amortization ("Adjusted EBITDA") over a three-year period beginning on January 1, 2020 and ended December 31, 2022. As a result, 171% of the target amount of PRSUs for this award were deemed earned and vested. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 22:59 UTC |
Jackson Denise LChief Legal Officer
|
Tax withholdingCommon Stock | 2,627 | $97.49 | $256,106.23 |
DisclosureSEC source: 0001209191-23-010857 · doc4.xml · nonDerivative · entry 2 Jackson Denise L · CIK 0001320242 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,253 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 22:59 UTC |
Jackson Denise LChief Legal Officer
|
GrantCommon Stock | 6,315 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-010857 · doc4.xml · nonDerivative · entry 1 Jackson Denise L · CIK 0001320242 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,880 F1 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 6, 2020. The ultimate number of PRSUs that could have been earned and vested under this award depended on the Company achieving or exceeding, annual year-over-year performance targets based, on a consolidated basis, a certain specified adjusted earnings before interest, taxes, depreciation and amortization ("Adjusted EBITDA") over a three-year period beginning on January 1, 2020 and ended December 31, 2022. As a result, 171% of the target amount of PRSUs for this award were deemed earned and vested. Read SEC document |
| January 15, 2023 Filed Jan 19, 2023 00:57 UTC | Exercise / conversionRestricted Stock Units · Derivative | 5,728 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-003869 · doc4.xml · derivative · entry 4 Knudson Jeffrey R · CIK 0001752946 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,728 Underlying: Common Stock · 5,728 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F6 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 15, 2023 and vest in three tranches on the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
|
| January 15, 2023 Filed Jan 19, 2023 00:57 UTC | Exercise / conversionRestricted Stock Units · Derivative | 1,598 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-003869 · doc4.xml · derivative · entry 3 Knudson Jeffrey R · CIK 0001752946 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,247 Underlying: Common Stock · 1,598 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 15, 2022 and vest in three tranches on the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
|
| January 15, 2023 Filed Jan 19, 2023 00:57 UTC | Tax withholdingCommon Stock | 457 | $103.86 | $47,464.02 |
DisclosureSEC source: 0001209191-23-003869 · doc4.xml · nonDerivative · entry 2 Knudson Jeffrey R · CIK 0001752946 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,017 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
|
| January 15, 2023 Filed Jan 19, 2023 00:57 UTC | Exercise / conversionCommon Stock | 1,141 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-003869 · doc4.xml · nonDerivative · entry 1 Knudson Jeffrey R · CIK 0001752946 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,474 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units. Read SEC document |
|
| January 15, 2023 Filed Jan 18, 2023 22:34 UTC |
Hagan Mark ChristopherChief Information and Digital
|
Exercise / conversionRestricted Stock Units · Derivative | 4,212 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-003820 · doc4.xml · derivative · entry 4 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,212 Underlying: Common Stock · 4,212 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F6 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 15, 2023 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| January 15, 2023 Filed Jan 18, 2023 22:34 UTC |
Hagan Mark ChristopherChief Information and Digital
|
Exercise / conversionRestricted Stock Units · Derivative | 1,332 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-003820 · doc4.xml · derivative · entry 3 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,706 Underlying: Common Stock · 1,332 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 15, 2022 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| January 15, 2023 Filed Jan 18, 2023 22:34 UTC |
Hagan Mark ChristopherChief Information and Digital
|
Tax withholdingCommon Stock | 461 | $103.86 | $47,879.46 |
DisclosureSEC source: 0001209191-23-003820 · doc4.xml · nonDerivative · entry 2 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,682 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
| January 15, 2023 Filed Jan 18, 2023 22:34 UTC |
Hagan Mark ChristopherChief Information and Digital
|
Exercise / conversionCommon Stock | 871 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-003820 · doc4.xml · nonDerivative · entry 1 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,143 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units. Read SEC document |
| January 15, 2023 Filed Jan 18, 2023 22:33 UTC |
Jackson Denise LChief Legal Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,706 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-003818 · doc4.xml · derivative · entry 4 Jackson Denise L · CIK 0001320242 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,706 Underlying: Common Stock · 3,706 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F6 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 15, 2023 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| January 15, 2023 Filed Jan 18, 2023 22:33 UTC |
Jackson Denise LChief Legal Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,172 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-003818 · doc4.xml · derivative · entry 3 Jackson Denise L · CIK 0001320242 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,381 Underlying: Common Stock · 1,172 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 15, 2022 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| January 15, 2023 Filed Jan 18, 2023 22:33 UTC |
Jackson Denise LChief Legal Officer
|
Tax withholdingCommon Stock | 344 | $103.86 | $35,727.84 |
DisclosureSEC source: 0001209191-23-003818 · doc4.xml · nonDerivative · entry 2 Jackson Denise L · CIK 0001320242 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,565 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
| January 15, 2023 Filed Jan 18, 2023 22:33 UTC |
Jackson Denise LChief Legal Officer
|
Exercise / conversionCommon Stock | 828 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-003818 · doc4.xml · nonDerivative · entry 1 Jackson Denise L · CIK 0001320242 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,909 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units. Read SEC document |
| January 15, 2023 Filed Feb 27, 2023 22:34 UTC Amendment |
Jackson Denise LChief Legal Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,706 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-013321 · doc4a.xml · derivative · entry 4 Jackson Denise L · CIK 0001320242 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,706 Underlying: Common Stock · 3,706 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F7 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 15, 2023 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F6 · derivative.expiration_date: Restricted Stock Units do not have an expiration date Read SEC document |
| January 15, 2023 Filed Feb 27, 2023 22:34 UTC Amendment |
Jackson Denise LChief Legal Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,172 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-013321 · doc4a.xml · derivative · entry 3 Jackson Denise L · CIK 0001320242 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,381 Underlying: Common Stock · 1,172 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F5 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 15, 2022 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F6 · derivative.expiration_date: Restricted Stock Units do not have an expiration date Read SEC document |
| January 15, 2023 Filed Feb 27, 2023 22:34 UTC Amendment |
Jackson Denise LChief Legal Officer
|
Tax withholdingCommon Stock | 344 | $103.86 | $35,727.84 |
DisclosureSEC source: 0001209191-23-013321 · doc4a.xml · nonDerivative · entry 2 Jackson Denise L · CIK 0001320242 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,562 F3 · kind: Number of shares withheld for tax purposes. F2 · balance_after: Due to an administrative error, the Form 4 filed by the reporting person on January 18, 2023 overstated the amount of securities beneficially owned following the reported transactions by 5,003 shares. This Form 4 is being amended and restated to reflect that, following the reported transactions, 14,906 and 14,562 securities were beneficially owned by reporting person, not 19,909 and 19,565, respectively, that were previously reported. The administrative error was carried forward to the Form 4 filed on February 17, 2023. Read SEC document |
| January 15, 2023 Filed Feb 27, 2023 22:34 UTC Amendment |
Jackson Denise LChief Legal Officer
|
Exercise / conversionCommon Stock | 828 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-013321 · doc4a.xml · nonDerivative · entry 1 Jackson Denise L · CIK 0001320242 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,906 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units. F2 · balance_after: Due to an administrative error, the Form 4 filed by the reporting person on January 18, 2023 overstated the amount of securities beneficially owned following the reported transactions by 5,003 shares. This Form 4 is being amended and restated to reflect that, following the reported transactions, 14,906 and 14,562 securities were beneficially owned by reporting person, not 19,909 and 19,565, respectively, that were previously reported. The administrative error was carried forward to the Form 4 filed on February 17, 2023. Read SEC document |
| January 15, 2023 Filed Mar 30, 2023 22:10 UTC Amendment |
Jackson Denise LChief Legal Officer
|
GrantRestricted Stock Units · Derivative | 3,706 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-021672 · doc4a.xml · derivative · entry 4 Jackson Denise L · CIK 0001320242 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,706 Underlying: Common Stock · 3,706 shares Expires not disclosed F4 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F7 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 15, 2023 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F6 · derivative.expiration_date: Restricted Stock Units do not have an expiration date Read SEC document |
| January 15, 2023 Filed Mar 30, 2023 22:10 UTC Amendment |
Jackson Denise LChief Legal Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,172 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-021672 · doc4a.xml · derivative · entry 3 Jackson Denise L · CIK 0001320242 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,381 Underlying: Common Stock · 1,172 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F5 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 15, 2022 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F6 · derivative.expiration_date: Restricted Stock Units do not have an expiration date Read SEC document |
| January 15, 2023 Filed Mar 30, 2023 22:10 UTC Amendment |
Jackson Denise LChief Legal Officer
|
Tax withholdingCommon Stock | 344 | $103.86 | $35,727.84 |
DisclosureSEC source: 0001209191-23-021672 · doc4a.xml · nonDerivative · entry 2 Jackson Denise L · CIK 0001320242 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,830 F3 · kind: Number of shares withheld for tax purposes. F2 · balance_after: This Form 4/A corrects an error in the total number of shares acquired upon the vesting of Restricted Stock Units, which was understated by 344 shares due to an administrative error. The same error occurred in the Reporting Person's Form 4s filed January 10, 2023 and January 6, 2023. The Form 4 filed on January 10, 2023 understated the Restricted Stock Units acquired by 370 shares, and the Form 4 filed on January 6, 2023 understated the Restricted Stock Units acquired by 530 shares and the Performance Restricted Stock Units acquired by 1,289 shares. The error flowed through to the reported amount of securities beneficially owned by the Reporting Person in the Form 4 filed February 17, 2023. Following the transaction on February 17, 2023, the Reporting Person held 17,518 shares of common stock. The amount reported in Column 5 of Table 1 has been updated to reflect the number of shares of common stock held by the Reporting Person following the reported transaction. Read SEC document |
| January 15, 2023 Filed Mar 30, 2023 22:10 UTC Amendment |
Jackson Denise LChief Legal Officer
|
Exercise / conversionCommon Stock | 1,172 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-021672 · doc4a.xml · nonDerivative · entry 1 Jackson Denise L · CIK 0001320242 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,174 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units. F2 · shares: This Form 4/A corrects an error in the total number of shares acquired upon the vesting of Restricted Stock Units, which was understated by 344 shares due to an administrative error. The same error occurred in the Reporting Person's Form 4s filed January 10, 2023 and January 6, 2023. The Form 4 filed on January 10, 2023 understated the Restricted Stock Units acquired by 370 shares, and the Form 4 filed on January 6, 2023 understated the Restricted Stock Units acquired by 530 shares and the Performance Restricted Stock Units acquired by 1,289 shares. The error flowed through to the reported amount of securities beneficially owned by the Reporting Person in the Form 4 filed February 17, 2023. Following the transaction on February 17, 2023, the Reporting Person held 17,518 shares of common stock. The amount reported in Column 5 of Table 1 has been updated to reflect the number of shares of common stock held by the Reporting Person following the reported transaction. F2 · balance_after: This Form 4/A corrects an error in the total number of shares acquired upon the vesting of Restricted Stock Units, which was understated by 344 shares due to an administrative error. The same error occurred in the Reporting Person's Form 4s filed January 10, 2023 and January 6, 2023. The Form 4 filed on January 10, 2023 understated the Restricted Stock Units acquired by 370 shares, and the Form 4 filed on January 6, 2023 understated the Restricted Stock Units acquired by 530 shares and the Performance Restricted Stock Units acquired by 1,289 shares. The error flowed through to the reported amount of securities beneficially owned by the Reporting Person in the Form 4 filed February 17, 2023. Following the transaction on February 17, 2023, the Reporting Person held 17,518 shares of common stock. The amount reported in Column 5 of Table 1 has been updated to reflect the number of shares of common stock held by the Reporting Person following the reported transaction. Read SEC document |
| January 15, 2023 Filed Mar 30, 2023 22:04 UTC Amendment |
Hagan Mark ChristopherChief Information and Digital
|
GrantRestricted Stock Units · Derivative | 4,212 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-021660 · doc4a.xml · derivative · entry 4 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,212 Underlying: Common Stock · 4,212 shares Expires not disclosed F4 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F7 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 15, 2023 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F6 · derivative.expiration_date: Restricted Stock Units do not have an expiration date Read SEC document |
| January 15, 2023 Filed Mar 30, 2023 22:04 UTC Amendment |
Hagan Mark ChristopherChief Information and Digital
|
Exercise / conversionRestricted Stock Units · Derivative | 1,332 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-021660 · doc4a.xml · derivative · entry 3 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,706 Underlying: Common Stock · 1,332 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F5 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 15, 2022 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F6 · derivative.expiration_date: Restricted Stock Units do not have an expiration date Read SEC document |
| January 15, 2023 Filed Mar 30, 2023 22:04 UTC Amendment |
Hagan Mark ChristopherChief Information and Digital
|
Tax withholdingCommon Stock | 461 | $103.86 | $47,879.46 |
DisclosureSEC source: 0001209191-23-021660 · doc4a.xml · nonDerivative · entry 2 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,893 F3 · kind: Number of shares withheld for tax purposes. F2 · balance_after: This Form 4/A corrects an error in the total number of shares acquired upon the vesting of Restricted Stock Units, which was understated by 461 shares due to an administrative error. The same error occurred in the Reporting Person's Form 4s filed January 9, 2023 and January 6, 2023. The Form 4 filed on January 9, 2023 understated the Restricted Stock Units acquired by 416 shares, and the Form 4 filed on January 6, 2023 understated the Restricted Stock Units acquired by 880 shares and the Performance Restricted Stock Units acquired by 1,454 shares. The error flowed through to the reported amount of securities beneficially owned by the Reporting Person in the Form 4s filed February 17, 2023 and March 10, 2023. Following the transaction on March 9, 2023, the Reporting Person held 29,283 shares of common stock. The amount reported in Column 5 of Table 1 has been updated to reflect the number of shares of common stock held by the Reporting Person following the reported transaction. Read SEC document |
| January 15, 2023 Filed Mar 30, 2023 22:04 UTC Amendment |
Hagan Mark ChristopherChief Information and Digital
|
Exercise / conversionCommon Stock | 1,332 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-021660 · doc4a.xml · nonDerivative · entry 1 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,354 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units. F2 · shares: This Form 4/A corrects an error in the total number of shares acquired upon the vesting of Restricted Stock Units, which was understated by 461 shares due to an administrative error. The same error occurred in the Reporting Person's Form 4s filed January 9, 2023 and January 6, 2023. The Form 4 filed on January 9, 2023 understated the Restricted Stock Units acquired by 416 shares, and the Form 4 filed on January 6, 2023 understated the Restricted Stock Units acquired by 880 shares and the Performance Restricted Stock Units acquired by 1,454 shares. The error flowed through to the reported amount of securities beneficially owned by the Reporting Person in the Form 4s filed February 17, 2023 and March 10, 2023. Following the transaction on March 9, 2023, the Reporting Person held 29,283 shares of common stock. The amount reported in Column 5 of Table 1 has been updated to reflect the number of shares of common stock held by the Reporting Person following the reported transaction. F2 · balance_after: This Form 4/A corrects an error in the total number of shares acquired upon the vesting of Restricted Stock Units, which was understated by 461 shares due to an administrative error. The same error occurred in the Reporting Person's Form 4s filed January 9, 2023 and January 6, 2023. The Form 4 filed on January 9, 2023 understated the Restricted Stock Units acquired by 416 shares, and the Form 4 filed on January 6, 2023 understated the Restricted Stock Units acquired by 880 shares and the Performance Restricted Stock Units acquired by 1,454 shares. The error flowed through to the reported amount of securities beneficially owned by the Reporting Person in the Form 4s filed February 17, 2023 and March 10, 2023. Following the transaction on March 9, 2023, the Reporting Person held 29,283 shares of common stock. The amount reported in Column 5 of Table 1 has been updated to reflect the number of shares of common stock held by the Reporting Person following the reported transaction. Read SEC document |
| January 15, 2023 Filed Mar 30, 2023 22:03 UTC Amendment | GrantRestricted Stock Units · Derivative | 5,728 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-021657 · doc4a.xml · derivative · entry 4 Knudson Jeffrey R · CIK 0001752946 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,728 Underlying: Common Stock · 5,728 shares Expires not disclosed F4 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F7 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 15, 2023 and vest in three tranches on the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F6 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
|
| January 15, 2023 Filed Mar 30, 2023 22:03 UTC Amendment | Exercise / conversionRestricted Stock Units · Derivative | 1,598 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-021657 · doc4a.xml · derivative · entry 3 Knudson Jeffrey R · CIK 0001752946 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,247 Underlying: Common Stock · 1,598 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F5 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 15, 2022 and vest in three tranches on the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F6 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
|
| January 15, 2023 Filed Mar 30, 2023 22:03 UTC Amendment | Tax withholdingCommon Stock | 457 | $103.86 | $47,464.02 |
DisclosureSEC source: 0001209191-23-021657 · doc4a.xml · nonDerivative · entry 2 Knudson Jeffrey R · CIK 0001752946 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,474 F3 · kind: Number of shares withheld for tax purposes. F2 · balance_after: This Form 4/A corrects an error in the total number of shares acquired upon the vesting of Restricted Stock Units, which was understated by 457 shares due to an administrative error. The amount reported in Column 5 of Table 1 has been updated to reflect the number of shares of common stock held by the Reporting Person following the reported transaction. Read SEC document |
|
| January 15, 2023 Filed Mar 30, 2023 22:03 UTC Amendment | Exercise / conversionCommon Stock | 1,598 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-021657 · doc4a.xml · nonDerivative · entry 1 Knudson Jeffrey R · CIK 0001752946 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,931 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units. F2 · shares: This Form 4/A corrects an error in the total number of shares acquired upon the vesting of Restricted Stock Units, which was understated by 457 shares due to an administrative error. The amount reported in Column 5 of Table 1 has been updated to reflect the number of shares of common stock held by the Reporting Person following the reported transaction. F2 · balance_after: This Form 4/A corrects an error in the total number of shares acquired upon the vesting of Restricted Stock Units, which was understated by 457 shares due to an administrative error. The amount reported in Column 5 of Table 1 has been updated to reflect the number of shares of common stock held by the Reporting Person following the reported transaction. Read SEC document |
|
| January 15, 2023 Filed Jan 17, 2024 22:50 UTC |
Grace CarolineDirector · Chief Executive Officer
|
GrantRestricted Stock Units · Derivative | 14,827 | $0.00 | $0.00 |
DisclosureSEC source: 0001142750-24-000007 · wk-form4_1705531800.xml · derivative · entry 3 Grace Caroline · CIK 0001705516 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,827 Underlying: Common Stock · 14,827 shares Expires not disclosed F3 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock F4 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 15, 2023 and vest in three tranches on the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| January 09, 2023 Filed Jan 10, 2023 21:39 UTC |
Jackson Denise LChief Legal Officer
|
SaleCommon Stock | 4,001 | $110.76 | $443,150.76 |
DisclosureSEC source: 0001209191-23-002801 · doc4.xml · nonDerivative · entry 4 Jackson Denise L · CIK 0001320242 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,078 F5 · kind: The sale of 4,001 shares of AMN Common Stock was affected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F6 · price: The price reported in this row represents a weighted average price of $110.76 per share. These shares were sold in multiple transactions at prices ranging from $110.41 to $111.04, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 06, 2023 Filed Jan 9, 2023 23:34 UTC |
Hagan Mark ChristopherChief Information and Digital
|
Exercise / conversionRestricted Stock Units · Derivative | 1,203 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-002627 · doc4.xml · derivative · entry 3 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,203 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 6, 2020 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F5 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
| January 06, 2023 Filed Jan 9, 2023 23:34 UTC |
Hagan Mark ChristopherChief Information and Digital
|
Tax withholdingCommon Stock | 416 | $107.16 | $44,578.56 |
DisclosureSEC source: 0001209191-23-002627 · doc4.xml · nonDerivative · entry 2 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,272 F2 · kind: Number of shares withheld for tax purposes. Read SEC document |
| January 06, 2023 Filed Jan 9, 2023 23:34 UTC |
Hagan Mark ChristopherChief Information and Digital
|
Exercise / conversionCommon Stock | 787 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-002627 · doc4.xml · nonDerivative · entry 1 Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,688 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units. Read SEC document |
| January 06, 2023 Filed Jan 10, 2023 21:39 UTC |
Jackson Denise LChief Legal Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,259 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-002801 · doc4.xml · derivative · entry 5 Jackson Denise L · CIK 0001320242 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,259 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: The Restricted Stock Units identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock. F8 · derivative.exercise_date: The Restricted Stock Units identified in this row were granted on January 6, 2020 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service. F9 · derivative.expiration_date: Restricted Stock Units do not have an expiration date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.